Contact HealthDay
Tel: 203.855.1400 or E-mail

News By Specialty

Allergy
Anesthesiology
Cardiology
Cosmetic Surgery
Critical Care
Dermatology
Diabetes & Endocrinology
Emergency Medicine
Family Practice
Gastroenterology
Geriatrics
Hematology & Oncology
HIV & AIDS
Infectious Disease
Internal Medicine
Nephrology
Neurology
Nursing
OBGYN & Women's Health
Ophthalmology
Orthopedics
Otolaryngology
Pain Management
Pathology
Pediatrics
Pharmacy
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology

Follow us on:

    


e-Healthcare Leadership Awards


Weight Loss Improves Sexual Function in Diabetes
Improves sexual function in obese women with type 2 diabetes

FRIDAY, June 14 (HealthDay News) -- Among obese women with type 2 diabetes and sexual dysfunction, weight loss significantly improves sexual function, according to a study published online June 11 in Diabetes Care.

Rena R. Wing, Ph.D., from Brown University in Providence, R.I., and colleagues randomly assigned 375 overweight and obese women with type 2 diabetes to intensive lifestyle intervention (ILI) or diabetes support and education as a control. Noting that female sexual dysfunction is a prevalent problem in this population of women, their sexual function was assessed via the Female Sexual Function Inventory.

The researchers found that half of the 229 women who reported being sexually active also had female sexual dysfunction at baseline. The ILI group had significantly greater weight loss after one year (7.6 versus 0.45 kg). Among women with sexual dysfunction, a significantly higher proportion of the ILI group remained sexually active (83 versus 64 percent), had significantly greater improvement on total scores and most domains of the Female Sexual Function Inventory, and were significantly more likely to experience remission of sexual dysfunction (28 versus 11 percent).

"Participation in ILI appeared to have beneficial effects on sexual functioning among obese women with diabetes, particularly in those who had female sexual dysfunction at baseline," Wing and colleagues conclude.

One author is a paid consultant for Palatin and Sprout Pharmaceuticals.

Abstract
Full Text (subscription or payment may be required)



Copyright © 2013 HealthDay. All rights reserved.

April 24, 2014

Archive Search

By Keyword:
By Category:
By Topic:

Related Articles

FDA Proposes Accelerated Medical Device Approval Plan

Vitamin D Levels Linked to Activity Level in Severely Obese CME

Research Initiatives Demonstrate Ways to Speed Stroke Care

AAN: Mild Cognitive Impairment May Hasten Death

Review: Sugar-Sweetened Drink Intake Tied to Elevated BP CME

Methylation-Specific Assay Can Detect Advanced Breast Cancer CME